"Dartmouth Cancer Center is one of the nation's premier facilities for cancer treatment and research. It is one of only 51 National Cancer Institute-designated comprehensive cancer centers in the United States. The Cancer Center provides a positive environment for treatment, cure, and recovery for patients with all forms of cancer. Patients receive technologically advanced cancer treatments and access to clinical trials of new treatments. Each patient is seen as an individual, and a specific treatment plan is developed by specialists who work directly with the patient, family, and referring physician. The Cancer Center is also a leader in improving the comfort and quality of life of patients."

During the past decade, Norris Cotton Cancer Center-North conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 30 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 20 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norris Cotton Cancer Center-North" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "NRG Oncology" with 17 trials sponsored, "Radiation Therapy Oncology Group" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored and "SWOG Cancer Research Network" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norris Cotton Cancer Center-North" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 6 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Norris Cotton Cancer Center-North" are "Prostate Cancer" (6 trials), "Breast Cancer" (4 trials), "Head and Neck Cancer" (4 trials), "Recurrent Breast Carcinoma" (4 trials) and "Adult Glioblastoma" (3 trials). Many other conditions were trialed in "Norris Cotton Cancer Center-North" in a lesser frequency.

Most popular intervention types in "Norris Cotton Cancer Center-North" are "Drug" (71 trials), "Radiation" (51 trials), "Other" (43 trials), "Biological" (28 trials) and "Procedure" (27 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (18 trials), "Biospecimen Collection" (14 trials), "Computed Tomography" (14 trials), "Laboratory Biomarker Analysis" (14 trials) and "Questionnaire Administration" (13 trials). Other intervention names were less common.

The vast majority of trials in "Norris Cotton Cancer Center-North" are 72 trials for "All" genders, 13 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Norris Cotton Cancer Center-North". undefined are not yet recruiting, 25 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Norris Cotton Cancer Center-North, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Norris Cotton Cancer Center-North, 2 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".